Watch live ????
— EU Medicines Agency (@EMA_News) January 18, 2022
We are now starting our regular press briefing on #COVID19 vaccines and treatments.
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
???? *****O0RYhquSWY
Repeated administration of #COVID19 #boosters with very short intervals might reduce the level of antibodies that can be produced at each administration. #EMAPresser
— EU Medicines Agency (@EMA_News) January 18, 2022
EMA has not yet seen data on the 4th dose. Currently, there is no evidence for the need of a 4th dose in the general population with the current #COVID19vaccines. #EMAPresser
— EU Medicines Agency (@EMA_News) January 18, 2022
Approval of #COVID19vaccines with a different composition requires clinical data that show a superior immune response than the one generated by the #boosters currently available. #EMAPresser
— EU Medicines Agency (@EMA_News) January 18, 2022
